2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1467624064 D.O.
Verify on CMS →

THEOFANIS MITSINIKOS, D.O.

Endocrinology, Diabetes & Metabolism Physician in STONY BROOK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 801 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
46%
generic claims · 54% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
69.6443/100
▼ 13 pts below national avg 83.1 · [object Object]
Industry payments
$26.3K
203 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

THEOFANIS MITSINIKOS, D.O. reported a CMS MIPS final score of 69.6443/100 — below the 83.1 national average — and filed 5,939 Medicare Part D claims in 2023.

69.6443/100
MIPS score · -13 vs avg
6K
Part D claims, 2023
46%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

THEOFANIS MITSINIKOS, D.O.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

70 8th percentile higher than 8% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). This entry sits in this band. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

THEOFANIS MITSINIKOS, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about THEOFANIS MITSINIKOS, D.O.?

Below national average

NPI registry status

Active

Issued 03/24/2008

NPI 1467624064

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

5,939 125% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

69.6443/100 13.455699999999993% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in New York

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers

New York providers

Endocrinology, Diabetes & Metabolism Physician share within New York

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within New York

Medicare quality performance — MIPS

THEOFANIS MITSINIKOS, D.O.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
69.6443/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 69.6443/100 vs national avg 83.1

0%100%National avg83%69.6%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) — 69.6443/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

THEOFANIS MITSINIKOS, D.O. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding D.O. credentials at 2500 NESCONSET HWY, STONY BROOK, NY, 11790, with a listed phone of (631) 751-2400. NPI 1467624064 was issued on 03/24/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MITSINIKOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,939 prescription claims written by this provider, covering 801 Medicare beneficiaries and totaling roughly $4.2 million in drug spend, split 54% brand-name and 46% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 69.6443/100 for the 2023 performance year (Quality 69.4362, Cost 39.566), compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2500 NESCONSET HWY
STONY BROOK, NY 11790

Provider Details

NPI 1467624064
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials D.O.
Gender Male
NPI Issued 03/24/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

69.6443
Final Score
Avg: 83.1
69.4362
Quality
39.566
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for THEOFANIS MITSINIKOS, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$26.3K

Largest payer

Mannkind Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to THEOFANIS MITSINIKOS, D.O.. To verify THEOFANIS MITSINIKOS, D.O.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

THEOFANIS MITSINIKOS, D.O. — brand share 54.0%
Specialty average (est.)

54% brand-name claims vs 46% generic, on 5,939 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,939
Total Claims
$4.2M
Total Drug Cost
801
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
16,365
Total Day Supply
489,775
Brand vs Generic
54% brand / 46% generic
Brand Drug Cost
$4.0M
Generic Drug Cost
$201K

Patient Demographics

Average Patient Age
74.5 years
Avg HCC Risk Score
1.28
Gender Split
62% female / 38% male
Age Distribution
<65: 45, 65-74: 341, 75-84: 352, 85+: 63

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What THEOFANIS MITSINIKOS, D.O. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Synthroid
Levothyroxine Sodium
726
Levothyroxine Sodium
650
Metformin Hcl Er
Metformin Hcl
461
Trulicity
Dulaglutide
304
Farxiga
Dapagliflozin Propanediol
286
Rosuvastatin Calcium
205
Atorvastatin Calcium
199
Ozempic
Semaglutide
192
Bydureon Bcise
Exenatide Microspheres
148
Metformin Hcl
145

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How THEOFANIS MITSINIKOS, D.O. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

THEOFANIS MITSINIKOS, D.O.'s 5,939 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MITSINIKOS.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is THEOFANIS MITSINIKOS, D.O.'s specialty?
THEOFANIS MITSINIKOS, D.O. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in STONY BROOK, New York. Credentials: D.O..
How much does THEOFANIS MITSINIKOS, D.O. prescribe under Medicare Part D?
In 2023, THEOFANIS MITSINIKOS, D.O. wrote 5,939 Medicare Part D claims totaling $4.2M in drug costs for 801 beneficiaries.
What is THEOFANIS MITSINIKOS, D.O.'s Medicare quality score?
THEOFANIS MITSINIKOS, D.O. has a CMS MIPS Final Score of 69.6443/100 (Quality: 69.4362, Cost: 39.566). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is THEOFANIS MITSINIKOS, D.O. located?
THEOFANIS MITSINIKOS, D.O. is located at 2500 NESCONSET HWY, STONY BROOK, NY, 11790. Phone: (631) 751-2400.
What is THEOFANIS MITSINIKOS, D.O.'s NPI number?
THEOFANIS MITSINIKOS, D.O.'s National Provider Identifier (NPI) is 1467624064, issued on 03/24/2008.
Does THEOFANIS MITSINIKOS, D.O. prescribe more brand-name or generic drugs?
THEOFANIS MITSINIKOS, D.O.'s prescribing is 54% brand-name and 46% generic drugs by claim count, with $4.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does THEOFANIS MITSINIKOS, D.O. prescribe most often?
Based on 2023 Medicare Part D data, THEOFANIS MITSINIKOS, D.O.'s most frequently prescribed drugs include Synthroid, Levothyroxine Sodium, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does THEOFANIS MITSINIKOS, D.O. accept Medicare?
THEOFANIS MITSINIKOS, D.O. appears in CMS Medicare data with 5,939 Part D claims and 801 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify THEOFANIS MITSINIKOS, D.O.'s credentials?
THEOFANIS MITSINIKOS, D.O.'s NPI is 1467624064 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology